<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Krings A</submitter><funding>German Federal Ministry of Health</funding><funding>Robert Koch-Institut</funding><pagination>62</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10938743</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To reach the global elimination goals of viral hepatitis B and C (HBC, HCV), human immunodeficiency virus (HIV) and other sexually transmitted infections as a public health threat by 2030, monitoring is needed. Staff members of drug services and opioid substitution treatment (OST) practices in Berlin and Bavaria recruited clients for a pilot study addressing the respective infections among people who injected drugs (PWID) in Germany, 2021/2022. Participants filled a questionnaire and were tested for HBV, HCV, HIV and syphilis using dried blood spots (DBS). We evaluated the study design to implement a feasible and accepted nationwide periodical monitoring among PWID and serve as an example for the implementation of similar monitoring systems in other countries.&lt;h4>Methods</pubmed_abstract><journal>Harm reduction journal</journal><pubmed_title>Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.</pubmed_title><pmcid>PMC10938743</pmcid><funding_grant_id>2520AUK701</funding_grant_id><pubmed_authors>Krings A</pubmed_authors><pubmed_authors>Zimmermann R</pubmed_authors><pubmed_authors>DRUCK 2.0-study group</pubmed_authors><pubmed_authors>Steffen G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.</name><description>&lt;h4>Background&lt;/h4>To reach the global elimination goals of viral hepatitis B and C (HBC, HCV), human immunodeficiency virus (HIV) and other sexually transmitted infections as a public health threat by 2030, monitoring is needed. Staff members of drug services and opioid substitution treatment (OST) practices in Berlin and Bavaria recruited clients for a pilot study addressing the respective infections among people who injected drugs (PWID) in Germany, 2021/2022. Participants filled a questionnaire and were tested for HBV, HCV, HIV and syphilis using dried blood spots (DBS). We evaluated the study design to implement a feasible and accepted nationwide periodical monitoring among PWID and serve as an example for the implementation of similar monitoring systems in other countries.&lt;h4>Methods</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-14T20:33:57.01Z</modification><creation>2026-06-25T03:07:55.259Z</creation></dates><accession>S-EPMC10938743</accession><cross_references><pubmed>38486197</pubmed><doi>10.1186/s12954-024-00977-0</doi></cross_references></HashMap>